CD163, a marker of the innate immune system showed borderline significance, indicating that further studies investigating predictive capacity of the innate immune system are warranted.
← all excerpts
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine.
3
—
—
The sentences
CD8 sTILs also showed a trend for improved OS in the non-luminal subtypes in univariate analysis, although this was not significant (HR 0.65 [0.38–1.12]) (Supplementary Figure S4) .
These results may be significant for future immunotherapy trials combining one or more conventional types of chemotherapy with immune therapy.